<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0020">
 <label>Table 4</label>
 <caption>
  <p>Summary of potential peptide therapies for COVID-19.</p>
 </caption>
 <alt-text id="at0030">Table 4</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Peptide Name</th>
    <th align="left">Sequence</th>
    <th align="left">Derived from</th>
    <th align="left">Target</th>
    <th align="left">IC
     <sub>50</sub>
    </th>
    <th align="left">Assay Format Tested</th>
    <th align="left">Phase</th>
    <th align="left">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">SBP1</td>
    <td align="left">IEEQAKTFLDKFNHEAEDLFYQS</td>
    <td align="left">ACE2 receptor</td>
    <td align="left">S protein</td>
    <td align="left">*</td>
    <td align="left">Kinetic binding assay using bio-layer interferometry (BLI)</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1140" ref-type="bibr">228</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">EK1C4</td>
    <td align="left">SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol</td>
    <td align="left">S protein, HR2 domain</td>
    <td align="left">S protein, HR1 domain</td>
    <td align="left">15.8 nM</td>
    <td align="left">cell-cell fusion assay, plaque reduction assays</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1105" ref-type="bibr">221</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">P9R</td>
    <td align="left">NGAICWGPCPTAFRQIGNCGRFRVRCCRI</td>
    <td align="left">β-defensin-4</td>
    <td align="left">Endosome acidification</td>
    <td align="left">0.9 μg/mL</td>
    <td align="left">plaque assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1150" ref-type="bibr">230</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">QS1</td>
    <td align="left">Ac-Abu-Tle-Leu-Gln-VS</td>
    <td align="left">Hybrid combinatorial substrate library (HyCoSuL)</td>
    <td align="left">M
     <sup>pro</sup>
    </td>
    <td align="left">n/a</td>
    <td align="left">Kinetic analysis</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0895" ref-type="bibr">179</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">VIR251</td>
    <td align="left">Ac-hTyr-Dap-Gly-Gly-VME</td>
    <td align="left">Hybrid combinatorial substrate library (HyCoSuL)</td>
    <td align="left">PL
     <sup>pro</sup>
    </td>
    <td align="left">n/a</td>
    <td align="left">Kinetic analysis</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0900" ref-type="bibr">180</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">VIR250</td>
    <td align="left">Ac-Abu(Bth)-Dap-Gly-Gly-VME</td>
    <td align="left">Hybrid combinatorial substrate library (HyCoSuL)</td>
    <td align="left">PL
     <sup>pro</sup>
    </td>
    <td align="left">n/a</td>
    <td align="left">Kinetic analysis</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0900" ref-type="bibr">180</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>*not available in the literature.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
